Can amyloidosis improve?;L'AMYLOSE PEUT-ELLE REGRESSER?

Revue du Praticien

Volumn 47, Issue 16, 1997, Pages 1798-1801

  Dray, Jean Marc ^a   Blétry, Olivier ^a  

^a FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CHLORAMBUCIL; COLCHICINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DIMETHYL SULFOXIDE; MELPHALAN; PREALBUMIN; PREDNISONE; IMMUNOGLOBULIN LIGHT CHAIN; SERUM AMYLOID A;

AMYLOIDOSIS; CHEMOTHERAPY; FAMILIAL MEDITERRANEAN FEVER; HUMAN; LIVER TRANSPLANTATION; MORTALITY; PROGNOSIS; SHORT SURVEY; SURVIVAL; CLASSIFICATION; GENETICS; METABOLISM; REVIEW;

AMYLOIDOSIS; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; PREALBUMIN; SERUM AMYLOID A PROTEIN;

EID: 0030846774     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (41)

1. Michael J, Jones NF. Spontaneous remissions of nephrotic syndrome in renal amyloidosis. B M J 1978 ; 1 : 1592.
2. Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemic amyloidosis. Blood 1991 ; 77 : 257-62.
3. Gertz MA, Kyle RA Secondary systemic amyloidosis : Response and survival in 64 patients. Medicine (Baltímore) 1991 ; 70 : 246-56.
4. Meyers S, Janowitz HD, Gumaste VV et al. Colchicine therapy of the renai amyioido-sis of ulcerative colitis. Gastroenterology 1988 ; 94 ; 1503-7.
5. Kuwertz-Bröking E, Koch HG, Everding AS et al. Colchicine for secondary nephropathic amyloidosis in cystic fibrosis. Lancet 1995 ; 345 : 1178-9.
6. Escalante A, Ehresmann R, Quismorio FP. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum 1991 ; 34 : 920-2.
7. Ravid M, Shapira L, Lang R, Kedar A. Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis. Ann Rheum Dis 1982 ; 41 : 587-92.
8. Shapiro DL Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. Arthritis Rheum 1995 ; 38 : 1851-4.
9. Ahlmen M, Ahlmen J, Svalander C, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rhumatol 1987 ; 6 : 27-38.
10. Blanche P, Menkes CJ. Traitement immunosuppresseur de l'amylose secondaire à la polyarthrite rhumatoïde et à la maladie de Still. Rev Rhum Mal Osteoartic 1992 ; 59 : 784-9.
11. David J, Vouyiouka O, Ansell BM, Hall A Woo P. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993 ; 2 : 85-90.
12. Schnitzer TJ, Ansell BM. Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum 1977 ; 20 (suppl 2) : 245-52.
13. Savolainen HA, Isomäki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993 ; 20 : 1201-3.
14. Falck HM, Tornroth T, Skrivfars B, Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand 1979 ; 205 : 651-6.
15. Hartman A, Holdaas H, Fauchald P et al. Fifteen years' experience with renal transplantation in systemic amyloidosis. Transplant Int 1992 ; 5 : 15-8.
16. Lagrue G, Koeger AC, Benaym JC, Sobel A. Colchicine et amylose rénale de la maladie périodique. Ann Med Interne (Paris) 1981 ; 132 : 496-500.
17. Zemer D, Pras M, Sohar E, Gafni J. Colchicine in familial mediterranean fever. N Engl J Med 1976 ; 294 : 170-1.
18. Lagrue G, Koeger AC, Sobel A. La colchicine peut-elle guérir l'amylose rénale de la maladie périodique ? Presse Med 1984 ; 13 : 2458.
19. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial mediterranean fever. N Engl J Med 1986 ; 314 : 1001-5.
20. Livneh A, Zemer D, Siegal B, Labor A, Sohar E, Pras M. Colchicine prevents kidney transplant amyloidosis in familial mediterranean fever. Nephron 1992 ; 60 : 418-22.
21. Mignon F, Méry Ph, Cuvelier R, Delons S, Meyríer A, Rottembourg J. L'insuffisance rénale de la maladie péríodique peut-elle bénéficier de méthodes thérapeutiques modernes ? Ann Med interne (Paris) 1981 ; 132 : 501-6.
22. Giraud P, Adoue D, Durand D, Delsol G, Ton That H, Suc JM. Transplantation rénale dans la maladie pèrìodique. Ann Med Interne (Paris) 1981 ; 132 : 507-10.
23. KiliActurgay S, Haberal M. Transplantation for renal amyloidosis. Ren Fail 1993 ; 15 : 629-33.
24. Shmueli D, Lustig S, Nakache et al. Renal transplantation in patients with amyloidosis due to familial mediterranean fever. Transplant Proc 1992 ; 24 : 1783-4.
25. Holmgren G, Steen L, Ekstedt J et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991 ; 40 : 242.
26. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996 ; 47 : 944-51.
27. Suhr OB, Holmgren G, Steen L et al. Liver transplantation in familial amyloidotic polyneuropathy. Transplantation 1995 ; 60 : 933-8.
28. Holmgren G, Ericzon BG, Groth CG et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993 ; 341 : 1113-6.
29. Thr-Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995 ; 91 : 962-7.
30. Dubrey S, Mendes L, Skinner M, Falk RH. Resolution of heart failure in patients with AL amyloidosis. Ann Intern Med 1996 ; 125 : 481-4.
31. Livneh A, Zemer D, Langevitz P, Shemer J, Sohar E, Pras M. Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum 1993 ; 23 : 206-14.
32. Cohen AS, Rubinow A, Anderson JJ et al. Survival of patients with primary (AL) amyloidosis. Am J Med 1987 ; 82 : 1182-90.
33. Kyle RA, Gertz MA, Greipp PR et at. A trial of three regimens for primary amyloidosis : colchicine alone, melphalan and predinosne, and meiphalan, prednisone, and colchicine. N Engl J Med 1997 ; 336 : 1202-7.
34. Kyle RA, Greipp PR, Carton JP, Gertz MA Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine. Am J Med 1985 ; 79 : 708-16.
35. Skinner M, Anderson JJ, Simms R et al Treatment of 100 patients with primary amyloidosis : a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996 ; 100 : 290-8.
36. Shibuya T, Murakawa M, Tsuda Y, Harada M. Successful treatment of primary amyloidosis with dimethylsulfoxide and cytoreductive chemotherapy. Interne Med 1992 ; 31 : 544-8.
37. Gianni L, Bellotti V, Gianni AM, Merlini G. New drug therapy of amyloidoses : Resorption of AL-type deposits with 4'-lodo-4'-Deoxydoxorubicin. Blood 1995 ; 86 : 855-61.
38. Van Buren M, Mené RJ, Verdonck LF, Verzijlbergen FJ, Lokhorst HM. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis. Ann Interne Med (Paris) 1995 ; 122 : 508-10.
39. Comenzo RL, Vosburgh E, Simms RW et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis. one-year follow-up in five patients. Blood 1996 ; 88 : 2801-6.
40. Kessler M, Netter P, Gaucher A. Outcome of dialysis-associated arthropathy and dialysis-related β2-microglobulin amyloidosis after renal transplantation. Rev Rhum (Engl ed) 1994 ; 61 : S93-S96.
41. Leball-Darné JL, Bardin T, Zingraff J et al. The effect of renal transplantation on dialysis associated arthropathy. Rev Rheum (Engl ed) 1994 ; 61 : S 89-S 92.